A Mid-Infrared Imaging Survey of Proto-Planetary Nebula Candidates

We present the data from a mid-infrared imaging survey of 66 proto-planetary nebula candidates using two mid-IR cameras (MIRAC2 and Berkcam) at the NASA Infrared Telescope Facility and the United Kingdom Infrared Telescope. The goal of this survey is to determine the size, flux, and morphology of the mid-IR emission regions, which sample the inner regions of the circumstellar dust shells of proto-planetary nebulae. We imaged these proto-planetary nebulae with narrow-band filters ($\Delta\lambda / \lambda \sim 10$) at wavelengths of notable dust features. With our typical angular resolution of 1\arcsec, we resolve 17 sources, find 48 objects unresolved, and do not detect 1 source. For several sources, we checked optical and infrared associations and positions of the sources. In table format, we list the size and flux measurements for all the detected objects and show figures of all the resolved sources. Images for all the detected objects are available on line in FITS format from the Astronomy Digital Image Library at the National Center for Supercomputing Application. The proto-planetary nebula candidate sample includes, in addition to the predominant proto-planetary nebulae, extreme asymptotic giant branch stars, young planetary nebulae, a supergiant, and a luminous blue variable. We find that dust shells which are cooler ($\rm T \sim 150$ K) and brighter in the infrared are more easily resolved. Eleven of the seventeen resolved sources are extended and fall into one of two types of mid-IR morphological classes: core/elliptical or toroidal. Core/elliptical structures show unresolved cores with lower surface brightness elliptical nebulae. Toroidal structures show limb-brightened peaks suggesting equatorial density enhancements. We argue that core/ellipticals have denser dust shells than toroidals.Comment: 32 pages, 5 tables, 2 e/ps figures (fig3 is available through ADIL [see text]), to be published in ApJS May 1999 issu

An HST Snapshot Survey of Proto-Planetary Nebulae Candidates: Two Types of Axisymmetric Reflection Nebulosities

We report the results from an optical imaging survey of proto-planetary nebula candidates using the HST. We exploited the high resolving power and wide dynamic range of HST and detected nebulosities in 21 of 27 sources. All detected reflection nebulosities show elongation, and the nebula morphology bifurcates depending on the degree of the central star obscuration. The Star-Obvious Low-level-Elongated (SOLE) nebulae show a bright central star embedded in a faint, extended nebulosity, whereas the DUst-Prominent Longitudinally-EXtended (DUPLEX) nebulae have remarkable bipolar structure with a completely or partially obscured central star. The intrinsic axisymmetry of these proto-planetary nebula reflection nebulosities demonstrates that the axisymmetry frequently found in planetary nebulae predates the proto-planetary nebula phase, confirming previous independent results. We suggest that axisymmetry in proto-planetary nebulae is created by an equatorially enhanced superwind at the end of the asymptotic giant branch phase. We discuss that the apparent morphological dichotomy is caused by a difference in the optical thickness of the circumstellar dust/gas shell with a differing equator-to-pole density contrast. Moreover, we show that SOLE and DUPLEX nebulae are physically distinct types of proto-planetary nebulae, with a suggestion that higher mass progenitor AGB stars are more likely to become DUPLEX proto-planetary nebulae.Comment: 27 pages (w/ aaspp4.sty), 6 e/ps figures, 4 tables (w/ apjpt4.sty). Data images are available via ADIL (http://imagelib.ncsa.uiuc.edu/document/99.TU.01) To be published in Ap

Two Subclasses of Proto-Planetary Nebulae: Model Calculations

We use detailed radiative transfer models to investigate the differences between the Star-Obvious Low-level-Elongated proto-planetary nebulae (SOLE PPNs) and DUst-Prominent Longitudinally-EXtended proto-planetary nebulae (DUPLEX PPNs) which are two subclasses of PPNs suggested by Ueta, Meixner, & Bobrowsky (2000). We select one SOLE PPN, HD 161796, and one DUPLEX PPN, IRAS 17150$-$3224, both of which are well studied and representative of their PPN classes. Using an axisymmetric dust shell radiative transfer code, we model these two sources in detail and constrain their mass-loss histories, inclination angles and dust composition. The physical parameters derived for HD 161796 and IRAS 17150$-$3224 demonstrate that they are physically quite different and that their observed differences cannot be attributed to inclination angle effects. If these calculations reflect a more general truth about SOLE vs. DUPLEX PPNs, then these two subclasses of PPNs are physically distinct with the SOLE PPNs derived from low mass progenitors and DUPLEX PPNs derived from high mass progenitors.Comment: Accepted by ApJ. 8 fig

Role of Electrode Placement as a Contributor to Variability in Cochlear Implant Outcomes

Suboptimal cochlear implant (CI) electrode array placement may reduce presentation of coded information to the central nervous system and consequently limit speech recognition

Trapping \u3ci\u3ePhyllophaga \u3c/i\u3espp. (Coleoptera: Scarabaeidae: Melolonthinae) in the United States and Canada using sex attractants.

The sex pheromone of the scarab beetle, Phyllophaga anxia, is a blend of the methyl esters of two amino acids, L-valine and L-isoleucine. A field trapping study was conducted, deploying different blends of the two compounds at 59 locations in the United States and Canada. More than 57,000 males of 61 Phyllophaga species (Coleoptera: Scarabaeidae: Melolonthinae) were captured and identified. Three major findings included: (1) widespread use of the two compounds [of the 147 Phyllophaga (sensu stricto) species found in the United States and Canada, males of nearly 40% were captured]; (2) in most species intraspecific male response to the pheromone blends was stable between years and over geography; and (3) an unusual pheromone polymorphism was described from P. anxia. Populations at some locations were captured with L-valine methyl ester alone, whereas populations at other locations were captured with L-isoleucine methyl ester alone. At additional locations, the L-valine methyl ester-responding populations and the L-isoleucine methyl ester-responding populations were both present, producing a bimodal capture curve. In southeastern Massachusetts and in Rhode Island, in the United States, P. anxia males were captured with blends of L-valine methyl ester and L-isoleucine methyl ester

The Reversal Intervention for Metabolic Syndrome (TRIMS) study: rationale, design, and baseline data

<p>Abstract</p> <p>Background</p> <p>Recent attention has focused on strategies to combat the forecast epidemic of type-2 diabetes (T2DM) and its major vascular sequelae. Metabolic syndrome (MetS) comprises a constellation of factors that increase the risk of cardiovascular disease (CVD) and T2DM. Our study aims to develop a structured self-management education programme for people with MetS, which includes management of cardiovascular and diabetes risk factors, and to determine its impact. This paper describes the rationale and design of the TRIMS study, including intervention development, and presents baseline data.</p> <p>Methods</p> <p>Subjects recruited from a mixed-ethnic population with MetS were randomised to intervention or control arms. The intervention arm received structured group education based on robust psychological theories and current evidence. The control group received routine care. Follow-up data will be collected at 6 and 12 months. The primary outcome measure will be reversal of metabolic syndrome in the intervention group subjects compared to controls at 12 months follow-up.</p> <p>Results</p> <p>82 participants (44% male, 22% South Asian) were recruited between November 2009 and July 2010. Baseline characteristics were similar for both the intervention (n = 42) and control groups (n = 40). Median age was 63 years (IQR 57 - 67), mean waist size 106 cm (SD ± 11), and prescribing of statins and anti-hypertensives was 51% in each case.</p> <p>Conclusion</p> <p>Results will provide information on changes in diabetes and CVD risk factors and help to inform primary prevention strategies in people with MetS from varied ethnic backgrounds who are at high risk of developing T2DM and CVD. Information gathered in relation to the programme's acceptability and effectiveness in a multi-ethnic population would ensure that our results are widely applicable.</p> <p>Trial registration</p> <p>The study is registered at ClinicalTrials.gov, study identifier: <a href="http://www.clinicaltrials.gov/ct2/show/NCT01043770">NCT01043770</a>.</p

Large expert-curated database for benchmarking document similarity detection in biomedical literature search

Document recommendation systems for locating relevant literature have mostly relied on methods developed a decade ago. This is largely due to the lack of a large offline gold-standard benchmark of relevant documents that cover a variety of research fields such that newly developed literature search techniques can be compared, improved and translated into practice. To overcome this bottleneck, we have established the RElevant LIterature SearcH consortium consisting of more than 1500 scientists from 84 countries, who have collectively annotated the relevance of over 180 000 PubMed-listed articles with regard to their respective seed (input) article/s. The majority of annotations were contributed by highly experienced, original authors of the seed articles. The collected data cover 76% of all unique PubMed Medical Subject Headings descriptors. No systematic biases were observed across different experience levels, research fields or time spent on annotations. More importantly, annotations of the same document pairs contributed by different scientists were highly concordant. We further show that the three representative baseline methods used to generate recommended articles for evaluation (Okapi Best Matching 25, Term Frequency-Inverse Document Frequency and PubMed Related Articles) had similar overall performances. Additionally, we found that these methods each tend to produce distinct collections of recommended articles, suggesting that a hybrid method may be required to completely capture all relevant articles. The established database server located at https://relishdb.ict.griffith.edu.au is freely available for the downloading of annotation data and the blind testing of new methods. We expect that this benchmark will be useful for stimulating the development of new powerful techniques for title and title/abstract-based search engines for relevant articles in biomedical research.Peer reviewe

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570